Dr.Reddys Laboratories reported INR11.14B in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Aspen Pharmacare APN:SJ ZAR 3.13B 232M
Bharat Petroleum BPCL:IN INR -3384800000 58.09B
Cipla CIPLA:IN INR 7.89B 1.03B
Dr.Reddys Laboratories DRRD:IN INR 11.14B 748M
Reliance Infra RELI:IN INR 157.92B 21.36B
Sun Pharmaceuticals SUNP:IN INR 22.62B 2.01B
UPL UPLL:IN INR 8.14B 630M